Sign In

Dimitar Dimitrov

Micar Innovation (Micar21.com) - Drug Discovery Factory - Improved structure based insilico drug design and AI.

Professional Background

Dimitar Dimitrov stands as an inspiring figure in the biotechnology sector, exemplifying leadership and innovation through his role as CEO and Founder of Micar Innovation, also known as Micar21. Under his guidance, Micar Innovation has carved out a significant niche as a drug discovery factory dedicated to enhancing the quality of life through groundbreaking research and development of novel drug molecules aimed at treating a diverse array of diseases. The company's comprehensive approach to drug discovery encompasses the entire process from initial research to the preclinical phase, utilizing cutting-edge in silico drug design techniques.

Dimitar's unique methodology involves a structured approach that includes the identification of target proteins linked to specific diseases, followed by sophisticated 3D structural designs. This process ensures that potential drug candidates not only address the intended health issues effectively but also consider their activity, selectivity, and ADMET properties, paving the way for successful clinical applications. His vision extends to ensuring that the drugs developed under Micar21 meet the needs of patients with conditions such as chronic pain, alcoholism, rare diseases, colorectal cancer, and many others. The drug pipeline at Micar Innovation features multiple promising candidates, such as MIC4578 for chronic pain and MIC2211 for hyperekplexia, showcasing a commitment to addressing unmet medical needs.

Education and Achievements

Dimitar Dimitrov's academic foundation was laid at Sofia University St. Kliment Ohridski, where he honed his expertise in the intricacies of biotech and pharmaceutical sciences. This robust educational background provided him with the theoretical knowledge and practical skills necessary to navigate the complex world of drug discovery and development.

Throughout his career, Dimitar has held various esteemed positions that have further cemented his reputation as a frontrunner in the biotech industry. He formerly served as a Member Of The Management Board at the Bulgarian Employers Association Innovative Technologies (BRAIT) and Ai Cluster Bulgaria, where he played a crucial role in fostering innovation and collaboration among industry leaders. Additionally, he has demonstrated his entrepreneurial spirit by founding and leading companies such as Pancreatic Pharmaceuticals and Bolka Pharmaceuticals. His commitment to supporting the life sciences sector is also reflected in his roles with the Bulgarian Bioscience Society and Health & Life Sciences Cluster Bulgaria.

Demonstrating versatility and a forward-thinking approach, Dimitar has also been actively involved in the management of Exact Sciences Foundation, positioning himself as a thought leader dedicated to advancing healthcare solutions.

Achievements

One of Dimitar's most significant achievements is the establishment of Micar21, which stands out in the biotechnology field for its innovative drug discovery processes. The company's roadmap emphasizes the importance of clinical proof-of-concept, recognizing it as a vital step towards the successful commercialization of new medicines. By focusing on drug development up to Phase 2a, Micar Innovation aims to license these products to the most suitable commercial partners, enhancing the chances of bringing effective treatments to market.

Through strategic partnerships and collaborations with other biotech firms, big pharma entities, and Contract Research Organizations (CROs), Dimitar continues to expand Micar Innovation's influence and reach within the neuroscience therapeutic arena. His openness to strategic collaborations and licensing deals underscores a commitment to innovation and shared success within the industry.

Overall, Dimitar Dimitrov’s career is a testament to the potential of biotechnology to transform healthcare. He continues to inspire his team at Micar Innovation, leading the charge in discovering and developing impactful medications that have the potential to save lives and improve quality of life globally.

Related Questions

How did Dimitar Dimitrov's education at Sofia University contribute to his expertise in drug discovery?
What are the key innovations implemented at Micar Innovation under Dimitar Dimitrov's leadership?
How does Micar Innovation's business model enhance the drug discovery process?
In what ways has Dimitar Dimitrov's previous experience influenced his current role at Micar21?
What impact do the drugs in Micar's pipeline, such as MIC4578 and MIC9211, have on their respective target diseases?
Dimitar Dimitrov
Add to my network

Location

Sofia, Sofia City, Bulgaria